β-上腺激素激素保护了胰腺切除的老鼠心脏中的线粒体代谢
Ross T Lindsay1,2,3, Louise Thisted4, Nora E Zois4,5
1Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. rosstlindsay@gmail.com.
Scientific reports
|August 21, 2024
概括
在1型糖尿病中,糖尿病患者的心脏可能会受到β-上腺素刺激的保护,在接受异二烯林治疗时显示出维护了线粒体呼吸和改变了基质代谢.
科学领域:
- 心脏病学 心脏病学
- 代谢研究研究 代谢研究
- 线粒体生物学 线粒体生物学
背景情况:
- 1型糖尿病导致心脏功能障碍,其特点是代谢和功能性改变.
- 糖尿病患者的心脏表现出对β-上腺素刺激的脱敏,这是心力衰竭的关键途径.
- 了解这些复杂的相互作用对于开发有效的治疗方法至关重要.
研究的目的:
- 在1型糖尿病大鼠模型中,研究β-上腺素刺激对心脏线粒体呼吸和基质代谢的影响.
- 为了测试糖尿病患者的心脏受到保护免受压力诱导的心肌病的假设.
- 探索糖尿病和上腺刺激对心脏功能的联合影响.
主要方法:
- 使用90%的胰腺切除术 (Px) 鼠标模型来模拟1型糖尿病.
- 服用异上腺素 (一种β-上腺激动剂) 来评估其对心脏功能的影响.
- 测量心脏线粒体呼吸能力和基质代谢.
- 监测死亡率和心肌能量状态.
主要成果:
- 胰腺切除术和异上腺素都单独抑制了心脏线粒体呼吸,但这在接受异上腺素的Px大鼠中得到了保留.
- 胰腺切除术导致脂肪酸和类代谢增加,而异上腺素提高了葡萄糖代谢.
- 皮克斯大鼠表现出对异上腺素诱导的死亡率的保护,具有高的cGMP和保存的心肌能量.
结论:
- 上腺刺激可能在1型糖尿病心脏中提供保护作用.
- 该研究强调了在疾病模型中检查综合病理特征的重要性.
- 这些发现表明糖尿病心肌病的潜在治疗途径.
更多相关视频
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.7K
12:24Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
14.7K
相关概念视频
01:26Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
421
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
421
01:25cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
01:31Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K